Barclays raised the firm’s price target on DaVita (DVA) to $158 from $143 and keeps an Equal Weight rating on the shares post the Q4 report. The company’s 2026 earnings outlook handily beat Street estimates driven by continued share repurchase, the elimination of Mozarc losses, and lower debt from refinancing, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DVA:
